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Quantitative, spectrally-resolved
intraoperative fluorescence imaging
Pablo A. Valdés1,2,3, Frederic Leblond1, Valerie L. Jacobs2, Brian C. Wilson5, Keith D. Paulsen1,2,4
& David W. Roberts2,3,4
1Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA, 2Dartmouth Medical School, Dartmouth College,
Hanover, NH 03755, USA, 3Section of Neurosurgery, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756,
USA, 4Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA, 5University of
Toronto, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
Intraoperative visual fluorescence imaging (vFI) has emerged as a promising aid to surgical guidance, but
does not fully exploit the potential of the fluorescent agents that are currently available. Here, we introduce a
quantitative fluorescence imaging (qFI) approach that converts spectrally-resolved data into images of
absolute fluorophore concentration pixel-by-pixel across the surgical field of view (FOV). The resulting
estimates are linear, accurate, and precise relative to true values, and spectral decomposition of multiple
fluorophores is also achieved. Experiments with protoporphyrin IX in a glioma rodent model demonstrate
in vivo quantitative and spectrally-resolved fluorescence imaging of infiltrating tumor margins for the first
time. Moreover, we present images from human surgery which detect residual tumor not evident with
state-of-the-art vFI. The wide-field qFI technique has broad implications for intraoperative surgical
guidance because it provides near real-time quantitative assessment of multiple fluorescent biomarkers
across the operative field.
T
he clinical foundation of surgical oncology is underpinned by the simple but universal premise that for most
solid tumors achieving complete resection improves patient outcomes. Unfortunately, despite significant
advances in surgical technology and technique1–4, rates of complete resection remain surprisingly low and/
or the need for re-excision persists in many primary cancers (e.g., in brain5,6, breast7, and prostate8, among others).
Intraoperative tissue characterization also enables conservation of normal tissue, which is critical to functional
preservation or patient satisfaction and quality of life. For example, re-excision rates in breast lumpectomy have
been reported to be as high as 40% in some studies9, largely because of residual disease found at the margin of the
resected specimen that was not apparent to the surgeon at time of procedure. Glandular preservation in prostate
cancer surgery is desirable clinically10, but has not been widely adopted because surgical margins have been difficult
to identify intraoperatively without histologically assessing the excised tissue in the operating room (OR)11.
Nowhere are the principles of complete resection and the application of technology to meet the concomitant
procedural challenges more evident than in neurosurgical oncology, where the highly invasive and infiltrative
nature of malignant glioma typically leads to recurrence12,13. Major technologies and procedural trends that apply
across surgical specialties (i.e., wide-field, white-light visualization of the surgical field through the operating
microscope (OM)14, navigational tracking15, image-guidance16, intraoperative imaging17, etc.) were born in
neurosurgery ORs, which have become a clinical platform for technology innovation and translation across all
of surgery.
The most recent advances, now found in many modern OMs, involve use of light at specific wavelength(s)
which stimulates fluorescent emissions from biomarkers that can be associated with specific tissues in the field-
of-view (FOV), and offer the hope of identifying disease, intraoperatively, at the cellular and/or molecular
levels2,18–20. Accordingly, visualization of protoporphyrin IX (PpIX) red fluorescence induced by oral administra-
tion of 5-aminolevulinic acid (ALA) has become standard-of-care for resection of high-grade glioma in Germany
based on outcomes from a randomized multi-center Phase III trial comparing progression free survival in patients
undergoing either fluorescence-guided resection or conventional resection under white light visualization18.
While these OMs have allowed surgeons wide-spread access to visual fluorescence imaging (vFI) in the OR, the
information is not quantitative and resection decisions have been reached based on subjective assessments of the
visible fluorescence (e.g., red fluorescence from PpIX) from the surgical surface. Current intraoperative vFI does
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between perceived fluorescence and actual biomarker concentration.
Indeed, vFI leaves significant tumor undetected22,23 – it does not take
full advantage of the specificity of fluorescent biomarkers (e.g.,
because diagnostic concentrations exist which are not visible22,23),
or their spectral signatures (e.g., because single bandpass or longpass
filters have typically been used to collect the fluorescence signal2,19).
Spectrally-resolved detection, i.e., detection of the full spectrum,
enables decomposition of non-specific autofluorescence in tissue,
which improves image contrast and detection accuracy of cancer-
specific biomarkers23,24. With the advent of intraoperative flu-
orescence imaging and accompanying fluorophores for surgical
guidance (e.g., PpIX18, folate receptor targets2, fluorescent peptides3,
blood pooling agents such as fluorescein and indocyanine green19,
etc.), decomposition of overlapping fluorescent agents from the same
emission signal becomes possible with spectrally-resolved appro-
aches, thus allowing simultaneous, spatially-coregistered in vivo
imaging of multiple reporters19,25.
In this paper, we present the first demonstration of wide-field
quantitative fluorescence imaging (qFI) in vivo for intraoperative
surgical guidance. Critical to this success is spectrally-resolved image
capture with concomitant correction of the emitted fluorescence for
tissue optical property variations and fast (near real-time) data pro-
cessing to estimate absolute fluorophore concentrations pixel-by-
pixel across the FOV. Quantitative results are reported for both
animal and human intracranial tumors in the intraoperative setting.
Here, we show pre-clinical imaging of PpIX and fluorescein in tissue,
resulting from simultaneous detection of full visible spectrum fluor-
escence in the same animal tumors. Quantitative identification of
more than one fluorophore within the same FOV offers new pos-
sibilities for simultaneously delineating multiple tissue characteris-
tics of critical importance to the surgeon. We also show the first
human results of qFI as a novel imaging technique to improve tumor
detection during the resection of glioblastoma multiforme (GBM).
While we present these results in the setting of neurosurgery, the data
acquisition and processing methods reported for intraoperative
wide-field qFI of absolute concentrations of multiple flourophores
are readily applied to other fluorescent reporters and/or surgical
oncology procedures.
Results
Phantom validation. Quantification of fluorophore concentration.
The quantitative performance of our wide-field qFI instrumentation
in terms of estimating fluorophore concentration was evaluated
and validated in phantoms. A spectrally-constrained dual band
normalization26 was used to correct the raw fluorescence signal for
the nonlinear distortions caused by tissue optical properties at both the
excitation and fluorescence emission wavelengths (Methods). The
approach compensates for varying optical attenuation in tissue
which enables quantification of absolute fluorophore concentrations.
Previously-validated, tissue-simulating liquid phantoms fabricated
with varying optical absorption (ma) and reduced scattering (ms’)
properties at the excitation and main emission peak of PpIX (l 5
405 nm and l 5 635 nm, respectively) were formed with increasing
PpIX concentrations from 0.02 to 5 mg/ml, commensurate with the
range commonly found in normal and pathological tissues. Table 1
summarizes the 9 combinations of absorption and scattering optical
properties that were mixed with each of 9 concentrations of PpIX
(total of 81 phantoms) (Methods).
We acquired spectrally-resolved, wide-field image data with our
qFI system to calculate pixel-specific PpIX concentrations, CPpIX,
across the FOV (Methods) and compared these values to the actual
PpIX concentrations shown in Figure 1. The linearity of the qFI
estimate with increasing CPpIX averaged over pixels for all 9 combi-
nations of phantom optical properties resulted in a coefficient of
determination, R2 5 0.88. The mean percentage error (mPE) in the
imaged CPpIX estimates was 24% (PE range: 0.3 – 71.4%). The mean
coefficient of variation (pixel standard deviation divided by pixel
mean), mCOV, is also shown in Figure 1 as a function of true
CPpIX for each optical phantom combination and indicates a mean
of 2.7% with a range from 0.1% to less than 45% (at the lowest PpIX
concentration of 0.02 mg/ml and highest optical absorption).
To relate these results to state-of-the-art vFI, we integrated the
area under the curve of the raw fluorescence signal, FRAW, over the
range l 5 6102720 nm in Figure 1. In this case, not only is the
linearity of the response to increasing CPpIX significantly degraded
(R2 5 0.27 for CPpIX . 0.30 mg/ml; R2 , 0.1 for CPpIX . 0.02 mg/ml),
but the CPpIX estimates are also less accurate (mPE 5 55%) when the
phantom optical properties were changed but CPpIX remained the
same.
Spectral decomposition of multiple fluorophores. We evaluated the
ability of our qFI system to spectrally resolve multiple fluorophores
by adding concentrations of fluorescein to the homogeneously dis-
tributed PpIX phantoms of increasing CPpIX. Figure 2 shows qFI
estimates as a function of increasing (true) CPpIX for 4 different
concentrations of fluorescein. Here, we considered CPpIX ranging
from 0.156 mg/ml to 1.25 mg/ml combined with fluorescein concen-
trations from 1.25 to 10 mg/ml which are representative of clinically
relevant concentrations23. The strongly linear and accurate relation-
ship between wide-field qFI-derived CPpIX estimates and the actual
PpIX concentrations was preserved (R2 5 0.99, mPE 5 13%) across
all FOVs and phantom concentrations (PE range: 0.5 and 56.3%).
COV response is also shown in Figure 2 and mCOV was 1.2%
(mCOV range: 0.2 – 9.2%).
Animal studies. In vivo qFI was evaluated in an established rodent
model of GBM, which displays the histopathological hallmarks of the
disease, including invasion of parenchyma and periventricular
spread with single cell infiltration. Animals implanted with CNS-1
tumors were given 100 mg/kg of ALA 2 hrs prior to surgery. At the
start of surgery, four (4) of these animals also received an i.v. injection
of 100 mg/kg of 10% fluorescein sodium solution. Exogenous ALA
administration leads to selective accumulation of PpIX in tumors
whereas fluorescein functions as a blood pooling agent, preferen-
tially accumulating in regions of leaky tumor vasculature.
Quantification of fluorophore concentration. In 4 of the animals
receiving only ALA, we compared wide-field qFI estimates of CPpIX
with in vivo spectroscopy probe recordings in both tumor and nor-
mal brain in multiple locations in each animal (for a total of n 5 41
samples). In previous work27, the accuracy of the probe was evaluated
in detail and the instrument was found to reproduce known phantom
and in vivo values of CPpIX with an error of less than 10%. Here, we
considered the probe readings to represent the gold standard for
CPpIX. In paired t-tests, no statistically significant differences were
found between the two data sets. Supplementary Figure 2 presents a
Table 1 | Phantom optical properties at lx 5 405 nm and lm 5
635 nm
ma,x(cm21) m’s,x(cm21) ma,m(cm21) m’s,m(cm21)
20 15 0.02 8.7
20 20 0.04 11.6
20 25 0.06 14.5
40 15 0.02 8.7
40 20 0.04 11.6
40 25 0.06 14.5
60 15 0.02 8.7
60 20 0.04 11.6
60 25 0.06 14.5
Optical absorption (ma) and reduced scattering (m’s) phantom combinations. Symbol used to
denote each case in Fig 1 is shown.
www.nature.com/scientificreports
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scatter plot of CPpIX estimates from the wide-field qFI image loca-
tions coregistered with the position of the probe against the probe
values. A linear relationship is evident with a statistically-significant
(p , 0.0001) correlation coefficient of R 5 0.79. When probe CPpIX
was greater than 40 ng/ml, mPE for the qFI estimates of CPpIX was
less than 35%.
Figure 3 shows a representative set of images from a typical animal
in the ALA-only group which illustrates white-light, vFI, qFI and
qFI1white-light views of the same surgical field. A red PpIX fluor-
escence is observed in the tumor bulk under vFI. Congruence
between the vFI and white-light indications of tumor is evident. Cor-
responding qFI maps of PpIX concentrations of the same FOV reveal
CPpIX . 150 ng/ml in the tumor bulk. Interestingly, infiltrating
tumor margins (CPpIX , 100 ng/ml) outside the tumor bulk are
evident on qFI, but not vFI (Fig. 3c, white arrow), demonstrating
improved margin delineation with qFI at PpIX concentrations which
were below the visual threshold for detection.
Spectral decomposition of multiple fluorophores. Four (4) animals
receiving doses of both ALA and fluorescein were imaged after sur-
gical exposure of the tumor to evaluate the spectral separation of the
contributions of these two fluorophores. Figure 4 shows represent-
ative results from a typical animal where white-light, vFI and qFI
views of the same surgical field are displayed. The vFI presentation in
the bulk tumor is visually dominated by the green fluorescein color.
The wide-field CPpIX image and the normalized fluorescein map
indicate localization of both molecules with greatest concentrations
in similar regions of the tumor bulk, but with some distributed het-
erogeneity (including in the immediately adjacent and surrounding
margin). Again, qFI detected significant levels of PpIX in the infil-
tration zone which would have otherwise gone undetected with vFI
(see arrows in Fig. 4C vs. Fig 4B). Sample spectra are also shown
which illustrate the decomposition of the relative contributions of
each fluorophore (and tissue autofluorescence) despite the lack of
visual discrimination.
Human studies. To date, surgical fields in 12 brain tumor patients
receiving 20 mg/kg of ALA approximately 3 hours prior to the
procedure have been assessed with the qFI system. Figure 5 shows
a comparison of vFI and qFI in a representative case. At the start of
this surgery, vFI indicates a heterogeneous distribution of PpIX
fluorescence whereas the corresponding qFI view demonstrates the
Figure 2 | Wide-field image estimate versus changing PpIX
concentration, CPpIX, in phantoms with different fluorescein
concentrations (10, 5, 2.5, 1.25 mg/ml). (A) Pixel-averaged qFI estimates
of CPpIX. (B) Coefficient of variation, COV, across the FOV. Multiple
points per CPpIX represent different fluorescein concentrations.
Figure 1 | Wide-field image estimate versus true PpIX concentration,
CPpIX, in phantoms with different absorption and scattering optical
properties (see Table 1). (A) Pixel-averaged qFI estimates of CPpIX.
(B) Coefficient of variation, COV, across the FOV. (C) Area under the raw
optical signal (fluorescence intensity) curve from 610–720 nm. R2 5
coefficient of determination; mPE 5 mean percentage error; mCOV 5
mean coefficient of variation.
www.nature.com/scientificreports
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presence of more significant, previously undetected tumor bio-
marker. Normal brain similarly does not show spectral evidence of
tumor based on the qFI view which was confirmed by probe
measurement. A similar series of image acquisitions near the end
of surgery in the same patient illustrates no evidence of disease in
the vFI view but histologically-confirmed residual tumor in the
qFI images. Corresponding spectra from histologically-confirmed
tumor-positive (near the end of surgery) and tumor-negative por-
tions (at the end of surgery) of the qFI-derived CPpIX map are shown
which demonstrate the presence and absence of PpIX signal,
respectively (Fig. 5L).
Discussion
In this paper, we describe the implementation and evaluation of a fast
(near real-time), quantitative and spectrally-resolved wide-field
fluorescence imaging approach for intraoperative identification
and delineation of tumor during surgery. Critical to the success of
the technique is acquisition of white-light reflectance spectra to cor-
rect the detected fluorescence for attenuation caused by tissue optical
absorption and scattering in the fluorescence excitation and emission
wavelength bands. The method produces quantitative estimates of
fluorophore concentration, but also enables spectral decomposition
of contributions from multiple fluorophores in the FOV.
Phantom results demonstrate the sensitivity and linearity of the
approach to PpIX fluorescence. Specifically, we detected PpIX con-
centrations as low as 20 ng/ml, independently of phantom optical
properties, with linear changes in the imaged signal to increases in
the true PpIX concentration up to 5000 ng/ml. The absolute accu-
racy in the wide-field CPpIX image estimates was better than 25% and
their precision resulted in a coefficient of variation across the image
of less than 10% for all optical property combinations provided CPpIX
was greater than 40 ng/ml. Our in vivo human data indicate that a
detection threshold of ,100 ng/ml will provide positive predictive
values in excess of 90%22,23. Importantly, qFI was at least an order of
magnitude more sensitive to PpIX concentration than vFI (,40 ng/
ml vs. ,600 ng/ml), and generated improved contrast (,10:1) at
concentrations at least one order of magnitude lower (,40 ng/ml vs.
,600 ng/ml for qFI compared to vFI, respectively).
Figure 3 | Wide-field qFI estimates of CPpIX in a rodent model of glioma. (A) White light FOV. (B) Corresponding vFI demonstrating red PpIX
fluorescence in the tumor bulk. (C) Map of qFI estimates of CPpIX. (D) Corresponding image overlay demonstrating CPpIX .150 ng/ml in the tumor bulk,
as well as significant (CPpIX ,100 ng/ml) PpIX in the infiltrating margin (white arrow). Color bar values are in ng/ml.
Figure 4 | Wide-field qFI in the presence of two fluorophores in a rodent model of glioma. (A) White light FOV. (B) Corresponding vFI demonstrates
green fluorescein fluorescence in the tumor bulk, and no visible PpIX red fluorescence. (C) Map of qFI estimates of CPpIX. (D) Corresponding image
overlay shows CPpIX .200 ng/ml in the tumor bulk. (E) Map of normalized fluorescein levels. (F) Corresponding image overlay demonstrates fluorescein
levels in the tumor bulk as well as diffusely scattered through normal brain. Significant PpIX concentration (CPpIX ,100 ng/ml) was found in the
infiltrating margin (white arrow in C) with minimal fluorescein present. Spectral decomposition (far right) indicates the varying contributions (at arrow
locations in B marked 1, top spectral plot, and *, bottom spectral plot) from each fluorophore in the FOV. Color bar values for C and D are in ng/ml and
for E and F in normalized arbitrary units.
www.nature.com/scientificreports
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Pre-clinical results in a rodent glioma model indicated that the
qFI-derived CPpIX was also linear with the response of our quantitat-
ive, direct-contact optical spectroscopy probe and yielded a highly
statistically significant (P, 0.001) correlation coefficient of 0.79
based on 41 measurements obtained from multiple animals. When
CPpIX measured with the probe was greater than 40 ng/ml, the mean
percentage error (assuming the probe is the gold standard) in the
in-vivo qFI-derived CPpIX estimates was 30% whereas the errors
exceeded 100% when all probe data were included. These results
are specific to this tumor biomarker and suggest that the in-vivo
sensitivity of the qFI technique is presently about 40 ng/ml which
is below the intraoperative threshold of 100 ng/ml based on our
clinical experience with PpIX to date22,23. In these animals, we
observed significant heterogeneity in the tumor bulk (with values
ranging from 50 ng/ml to 500 ng/ml), and CPpIX levels up to
100 ng/ml in the infiltrating margins that were not visibly apparent
with vFI. These data indicate that our qFI technique can not only
detect the more infiltrating margins of tumor, but also yields absolute
concentrations with reasonable accuracy.
The importance of qFI relative to state-of-the-art vFI was particu-
larly evident, and equally convincing, in the animals receiving both
ALA and fluorescein as shown in Figure 4 where the vFI view is sub-
stantially altered by the presence of fluorescein. Again, substantial
PpIX concentration (CPpIX . 200 ng/ml) is recovered in the tumor
bulk that was not visually evident, and weaker but still accurate, PpIX
concentrations (CPpIX , 100 ng/ml) are found in the infiltrating
tumor margins, providing evidence of improved detection of invas-
ive disease. An important caveat to these results is that the fluorescein
images are not quantitative (rather normalized) because we did not
determine the qFI calibration factors or investigate the optimal
excitation/emission normalization bands to correct for tissue optical
property distortions of the fluorescein fluorescence signal. While this
optimization and calibration can be done, the non-quantitative nat-
ure of the fluorescein images does not diminish the significance of the
PpIX results nor the ability to decompose measured spectra into
estimates of absolute concentrations of multiple fluorophores.
Quantitative, multiple reporter imaging opens the door to novel
fluorescence detection approaches in the intraoperative setting
(e.g., measurement of reporter kinetics28).
The human data near the end of surgical resection was even more
compelling in terms of the clinical importance of wide-field qFI
surveillance. When tumor appeared to be completely removed by
vFI, previously unidentified infiltrative tumor was evident with qFI
enabling further resection (see Figure 5). In addition, wide-field qFI
provided efficient detection compared with impractical, point-
by-point application of a quantitative probe. These results suggest
Figure 5 | Wide-field qFI during a human GBM surgery. Images at the beginning (A–C), near the end (E–G), and at the end of the case (I–K) show vFI,
white light, and white light1qFI views, respectively. High levels of PpIX are evident at the start of surgery (in B), whereas near the end of surgery, no PpIX
is noted on vFI (in F), but significant PpIX was found in qFI near the center of the FOV (in G) with histological corroboration as tumor (in L). At the end
of surgery, no significant PpIX levels remained in the qFI acquisition (in K). Spectra obtained at the beginning of surgery (in D) from three locations (1 5
vFI positive tumor, red mark in A; 25 qFI positive/vFI negative tumor, blue mark in A; 3 5 normal brain, green mark in A), and spectrum acquired near
the end of surgery (in H) from one location (1 5 qFI positive/vFI negative tumor, blue mark in E) are shown.
www.nature.com/scientificreports
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improved infiltrative tumor margin detection will be possible with
our quantitative qFI technique.
While the qFI results presented in this paper are impressive (par-
ticularly the data in phantoms where the true CPpIX values are known
and can be accurately quantified), further advances are likely to
improve the wide-field qFI accuracy, especially in vivo at concentra-
tions below 40 ng/ml. For example, better instrumentation fidelity (a
more sensitive camera and powerful light source) should increase the
accuracy of the technique. Further, the approach described here
relies on normalization with respect to pre-selected excitation and
fluorescence emission wavelength bands which have been optimized
to correct for the attenuation effects of tissue optical properties. A
model-based strategy that compensates the fluorescence signal by
explicitly estimating tissue optical absorption and scattering across
the full spectrum, is anticipated to be more accurate and reduce
dependencies on instrumentation and measurement calibration/
scaling factors to convert the raw signal acquisitions into concentra-
tion estimates21,27. Based on our experience during the development
of the quantitative optical probe (which applies full-spectrum ana-
lyses), in vivo errors below 20% appear possible, although at the
expense of considerably more computational effort that may be dif-
ficult to execute in near real-time in the OR.
In conclusion, we present a novel wide-field imaging technique,
qFI, which provides quantitative and spectrally resolved images of
fluorophore concentrations in (residual tumor) tissue, and readily
integrates into the surgical workflow. Our approach demonstrates
improved detection of residual disease compared to state-of-the-art
vFI that could increase the completeness of tumor resection with
preservation of normal function, which is known to correlate with
improved patient outcomes. This method has potential for broad
impact across other surgical oncology applications and in the detec-
tion of other fluorescent biomarkers of disease, including those that
may be present simultaneously.
Methods
Quantitative fluorescence imaging (qFI) system design. The quantitative
fluorescence imaging (qFI) system used in this study (dimensions 5 22.0 cm x 5.0 cm
x 8.5 cm, weight 5 900 g) consisted of three main components: a custom optical
adapter, a liquid crystal tunable filter (LCTF) (Cambridge Research Instruments), and
a charged-coupled device (CCD) camera (PCO.Pixelfly, Cooke Corp.) connected to a
computer control system as shown schematically and physically in Supplementary
Figure 1. The custom adapter attached these components (LCTF and camera) to an
optical port on a Zeiss Pentero OM, whereas commercially available components and
optics (Edmund Optics) connected the LCTF and CCD camera. The LCTF performed
fast (50 ms) single-band filtering (7 nm full-width at half-maximum) of incoming
light in the visible range, l 5 400 – 720 nm, and displayed a wavelength specific
response with a maximum transmittance of 64% at 710 nm. The CCD camera (1396 x
1024 pixels; 2 x 2 binning; 62% quantum efficiency at 580 nm) sensed incoming light
and transmitted the digital data to a computer control system. It had an enhanced red-
near-infrared mode which improved sensitivity in that spectral region. Custom
LabViewH software (National Instruments, Austin, TX) integrated control of the data
acquisition, processing, and image display.
The surgeon’s FOV through the OM was co-registered with the qFI data, providing
one-to-one comparisons. At standard working distances between the OM and sur-
gical field, the maximum and minimum FOVs were 50 mm x 40 mm and 10 mm x
7.5 mm, respectively. Spectrally-resolved acquisition ranged from 2 to 8 seconds per
white light and fluorescence image capture. Here, we operated in the visible portion of
the spectrum to image two clinically-approved fluorescent dyes (i.e., PpIX and
fluorescein). With the advent of imaging agents in the near infrared (NIR)25,29, the
design could accommodate either an LCTF operating in the NIR or a dual visible-NIR
LCTF.
Spectrally-resolved quantitative fluorescence imaging data. Each qFI acquisition
captured a 3D image cube at 5 nm spectral resolution (for l 5 450 – 720 nm) under
white light exposure followed by a 3D image cube at 3 nm spectral resolution (e.g., for
l5 600 – 720 nm for PpIX or 500 – 720 nm for PpIX plus fluorescein) during violet-
blue light exposure. Wavelength range selection was electronic and depended on the
wavelength region of interest so as to cover the main spectral features of each imaging
agent.
A 3D image cube (x, y, l) was stored as a series of 2D spatial images (x, y) at a
specific wavelength (l). Each individual pixel’s spatial coordinate (x, y) corresponded
to a location in the surgical field. We reconstructed spectrally-resolved (i.e., 1 nm
resolution) full reflectance and fluorescence spectra for each pixel coordinate using a
cubic spline interpolation, thereby generating a total of 723,840 spectra (696 x 520
5361,920 pixels x 2 exposures).
Tissue attenuation correction algorithm. The white light reflectance spectra
corrected the detected fluorescence for the attenuation caused by tissue optical
absorption and scattering21. Spectrally-constrained dual band normalization26 was
used to estimate the intrinsic fluorescence independently of the effects of tissue optical







where WFluoRaw lð Þ is the wavelength dependent, raw fluorescence intensity; WRefx and
WRefm are the reflectance signals integrated over the ranges l 5 4652485 nm and l 5
6252645 nm, respectively; and V is a calibration factor that depends on the light
source power. The range for WRefx was selected to be close to the excitation wavelength
band (i.e., 405 nm) to approximate light attenuation from excitation, whereas the
range for WRefm was chosen for the main emission peak of PpIX around l 5 635 nm.
Our correction algorithm assumed that most of the light attenuation is due to
absorption at the excitation wavelength, but scattering at the emission band can also
be corrected with an empirical power function, a, of WRefm (a 5 20.7).
We applied this attenuation correction to each pair of reflectance and fluorescence
image cubes. For each pixel coordinate (xi, yi), we integrated the reflectance spectrum
to calculateWRefx (i) andW
Ref
m (i), and estimated the corrected fluorescence,W
Fluo
Corrected ið Þ,
at each pixel by normalizing its raw fluorescence spectrum, WFluoRaw ið Þ by these
quantities. A least-squares estimate was applied to corrected fluorescence spectra to
spectrally decompose the individual contributions of the main fluorophores: PpIX,




where B 5 [b1b2…bN] is a matrix of basis spectra for N fluorophore components (e.g.,
PpIX, fluorescein, autofluorescence), and Crel is a relative concentration fluorophore
vector. A system-specific calibration factor, Scal, derived from the least squares
regression of phantom data of known PpIX concentrations converted the spectrally




Tissue phantoms. Liquid phantoms that simulate brain tissue (and tumor) optical
properties at the excitation and emission wavelengths were fabricated from a dye
(McCormick) as the main absorber and Intralipid as the scattering medium. A total of
nine (9) phantoms of three (3) different optical absorption (ma,x 5 20, 40, and
60 cm21) and scattering values (m’s,m 5 8.7, 11.4, and 14.5 cm21) were constructed
(see Table 1). For each set of phantom optical properties, nine (9) PpIX
concentrations covering the range found in brain tumors (0.019, 0.039, 0.078, 0.156,
0.313, 0.625, 1.250, 2.500, and 5.000 mg/ml) were added to produce a total of 81
phantoms of varying optical absorption, scattering and PpIX concentrations.
We acquired a pair of reflectance and fluorescence image cubes from each phantom
under the low-light conditions typically found in the operating room during fluor-
escence-guided surgery. Each pair was processed with the spectrally-constrained
normalization to form a PpIX concentration image. A region of interest corres-
ponding to (xi, yi) pixel coordinates in the raw fluorescence image cube and in the
calculated PpIX concentration image was identified for each phantom and used to (i)
integrate the average area-under-the-curve intensity in the 610–720 nm range for the





Raw lð ÞdlÞ, and (ii) construct the average
PpIX concentration, CPpIX, for the quantitative image map. The former represents the
raw PpIX fluorescence, and is equivalent to using a bandpass filter to extract the signal
in the range of interest. We also acquired images with the Zeiss Pentero surgical
microscope adapted for visual fluorescence imaging (vFI). Briefly, fluorescence light
in the range 450–720 nm was collected on a RGB CCD camera, and qualitative
assessments of the level of visible fluorescence were made.
FRAW and qFI-derived CPpIX were obtained as a function of the true PpIX con-
centrations in each phantom. Linear regression was used to define the linearity in the
fluorescence response with fluorophore concentration and the detection limits of
both approaches.
Spectral decomposition of PpIX and fluorescein concentrations was evaluated with
sixteen (16) additional phantoms at four different fluorescein concentrations (10, 5,
2.5, 1.25 mg/ml) and four PpIX concentrations (1.25,0. 625, 0.313, 0.156 mg/ml) with
ma,x 5 40 cm21 and m’s,m 511.4 cm21. For each phantom, reflectance and fluor-
escence image cubes were acquired and our correction algorithm applied.
Animal studies. These studies were approved by the Institutional Animal Care and
Use Committee (IACUC) at Dartmouth. Eight (8) Lewis rats were anesthetized by
inhalation of isoflurane (2–4%) in 100% O2. A 3 cm skin incision was made in the top
of the cranium, a small bur hole drilled, and 5x105 CNS-1 tumor cells injected into the
right striatum, and the wound closed using suture. The CNS-1 tumor cell line was
chosen because it exhibits the histopathological hallmarks of human GBM, including
invasion of parenchyma and periventricular spread with single cell infiltration30.
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Tumors were grown for two weeks, and on day 14 post-implantation, rats were given
an i.p. dose of 100 mg/kg of ALA (Sigma) two hours prior to imaging. Animals were
anesthetized for surgery by inhalation of isoflurane (2–4%) in 100% O2 and a
craniotomy performed, the dura removed, debris cleared, the brain exposed, and
imaging performed. In 4 of the rats, an i.v. dose of 100 mg/kg of 10% fluorescein
sodium solution in deionized water was administered post-dura opening.
Clinical studies. The Committee for the Protection of Human Subjects (CPHS),
which governs the participation of humans in research at Dartmouth, approved our
studies, and all patients participated under informed consent. Approximately 3 hours
prior to the induction of anesthesia, patients were given an oral dose (20 mg/kg) of
ALA (DUSA Pharmaceuticals, Tarrytown, NY, USA) dissolved in 100 ml of water.
At the discretion of the surgeon (DWR), the OM light was switched from white to
blue exposure, and digital images of visible fluorescence, and reflectance and fluor-
escence image cubes were acquired. Coregistered probe measurements and biopsy
specimens were collected with the latter immediately processed for subsequent his-
topathological analysis.
Histopathology. Histopathological analysis was performed on human formalin fixed
paraffin embedded tissue and processed for H&E staining.
Data processing and analysis. Data processing and analysis were performed with
MATLABH software (Version R2010a, The Mathworks, Inc., Natick, MA, USA).
Linear regression yielded the coefficient of determination, R2. Paired Student’s t-test
was used to compare differences. Pearson’s correlation coefficient was calculated to
evaluate linearity between variables. Two-sided P , 0.05 was considered statistically
significant.
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